A new dosage to reduce adverse gastrointestinal effects of gefitinib

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:xiaopp1920
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Gefitinib is the first epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI),which is often prescribed for non-small-cell lung cancer therapy with serious adverse effects on gastrointestinal physiology, such as nausea, vomiting, diarrhea and emaciation.
其他文献
  Angelica sinensis polysaccharide(ASP), extracted and purified from the root of Angelica sinensis,mainly consists of arabinose, glucose and galactose in a mo
会议
  RNA-cleaving DNAzymes have been used as a tool for target detection and gene silencing under physiologic conditions over the last two decades.However, despi
会议
会议
  Elacridar (ELC), a reversal agent of multidrug resistance (MDR), has been demonstrated as an excellent P-glycoprotein (P-gp) inhibitor which could reverse P
会议
  Objective Andrographolide (AND) is a chemical entity of a traditional Chinese medicine and widely used for anti-respiratory inflammation.Many oral formulati
会议
  To reduce the resistance of cancer cells against cisplatin, dry powder inhalation of Survivin siRNA and MRP1 siRNA loaded liposome for lung cancer therapy w
会议
  Active targeting drug delivery system is an effective strategy in cancer therapy currently, and among all the methods, peptide-mediated targeting of tumors
会议
  Mesenchymal stem cells (MSCs) have been extensively investigated to treat a wide range of diseases due to their easy accessibility, high self-renewal capaci
会议
会议
  Objective: To prepare UCNP-Ce6 hybrids and investigate its upconversion luminescence imaging and MRI dual-modal imaging properties as well as its in vitro/i
会议